Inactive Instrument
Cellivery Therapeutics, Inc. Stock
Stocks
A268600
KR7268600004
Biotechnology & Medical Research
| 1 day | -30.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
CEO | Chief Executive Officer | 58 | 28/08/2014 |
Byung-Hwa Lee
AUD | Comptroller/Controller/Auditor | 62 | 22/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
BRD | Director/Board Member | 58 | 28/08/2014 |
Yung-Ki Baek
BRD | Director/Board Member | 73 | 31/03/2023 |
Hyung Kim
BRD | Director/Board Member | 40 | 29/03/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.43% | -75.38% | - | - | 400K | |
| -0.10% | +0.10% | +74.33% | +133.26% | 57.73B | |
| -3.80% | -6.24% | +67.04% | +86.36% | 54.69B | |
| +0.60% | +1.77% | -13.95% | -11.38% | 23.75B | |
| +1.85% | +5.77% | +16.32% | +467.82% | 24.18B | |
| -2.70% | +4.25% | +40.38% | -3.72% | 19.82B | |
| +3.78% | +5.65% | +44.99% | -26.23% | 17.14B | |
| +3.46% | +17.72% | +206.66% | +364.07% | 16.75B | |
| -1.81% | +18.00% | +41.99% | - | 15.57B | |
| +2.97% | +5.63% | +30.15% | +197.64% | 13.96B | |
| Average | -2.61% | +5.56% | +56.44% | +150.98% | 27.06B | |
| Weighted average by Cap. | -0.29% | +3.34% | +58.00% | +139.42% |
Employees
4
Choose MarketScreener 
